Stockscreener 앱 받기
1.41%
전일 마감가:
$303.68
열려 있는:
$305.04
하루 거래량:
678.09K
Relative Volume:
0.38
시가총액:
$36.97B
수익:
$137.20B
순이익/손실:
$1.15B
주가수익비율:
32.96
EPS:
9.3439
순현금흐름:
$1.27B
1주 성능:
+0.93%
1개월 성능:
+41.65%
6개월 성능:
+35.60%
1년 성능:
+35.58%
1일 변동 폭
$302.00
$309.21
1주일 범위
$293.36
$315.66
52주 변동 폭
$163.11
$315.66
휴매너 Stock (HUM) Company Profile
명칭
Humana Inc
전화
(502) 580-1000
주소
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
307.95 | 36.46B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
388.47 | 347.35B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
93.26 | 119.07B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
394.69 | 84.65B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
286.24 | 74.60B | 278.13B | 6.74B | 7.66B | 23.60 |
휴매너 Stock (HUM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2026-01-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-12-05 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-10-14 | 개시 | Goldman | Sell |
| 2025-09-22 | 개시 | Evercore ISI | In-line |
| 2025-05-01 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2024-11-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2024-10-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-10-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-10-07 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-10-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-10-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-10-02 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-10-02 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-06-24 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-04-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-03-22 | 개시 | Raymond James | Mkt Perform |
| 2024-03-13 | 다운그레이드 | Argus | Buy → Hold |
| 2024-03-06 | 개시 | Barclays | Equal Weight |
| 2024-01-26 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2024-01-25 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-12-12 | 업그레이드 | Argus | Hold → Buy |
| 2023-11-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-07-07 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-06-23 | 다운그레이드 | Argus | Buy → Hold |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-10-26 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-09-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-06-17 | 개시 | Loop Capital | Buy |
| 2022-05-27 | 개시 | Bernstein | Mkt Perform |
| 2022-04-13 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-14 | 개시 | Goldman | Neutral |
| 2021-11-04 | 재확인 | Barclays | Overweight |
| 2021-11-04 | 재확인 | Credit Suisse | Outperform |
| 2021-11-04 | 재확인 | Morgan Stanley | Overweight |
| 2021-11-04 | 재확인 | Oppenheimer | Outperform |
| 2021-11-04 | 재확인 | RBC Capital Mkts | Outperform |
| 2021-09-27 | 개시 | SVB Leerink | Outperform |
| 2021-09-10 | 개시 | Cowen | Outperform |
| 2021-09-09 | 재개 | Barclays | Overweight |
| 2021-07-09 | 개시 | Seaport Global Securities | Neutral |
| 2021-05-19 | 개시 | Wells Fargo | Equal Weight |
| 2021-01-04 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-10-02 | 개시 | Bernstein | Mkt Perform |
| 2020-07-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-16 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-06-05 | 개시 | Goldman | Buy |
| 2020-01-03 | 재확인 | JP Morgan | Overweight |
| 2019-10-18 | 개시 | Mizuho | Buy |
| 2019-09-30 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-08-12 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-04-23 | 개시 | UBS | Neutral |
| 2019-01-14 | 개시 | Stephens | Overweight |
| 2018-12-20 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-11-08 | 재확인 | BofA/Merrill | Buy |
| 2018-09-13 | 개시 | Barclays | Overweight |
| 2018-07-12 | 재개 | Morgan Stanley | Overweight |
| 2018-07-06 | 재확인 | Piper Jaffray | Overweight |
| 2018-06-01 | 재개 | Citigroup | Buy |
| 2018-02-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-02-08 | 재확인 | Leerink Partners | Outperform |
| 2018-01-12 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
휴매너 주식(HUM)의 최신 뉴스
PNC Financial Services Group Inc. Decreases Stake in Humana Inc. $HUM - MarketBeat
UBS Adjusts Price Target on Humana to $320 From $262, Maintains Neutral Rating - marketscreener.com
Pzena Investment Management LLC Purchases 41,125 Shares of Humana Inc. $HUM - MarketBeat
Newport Trust Company LLC Decreases Position in Humana Inc. $HUM - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Humana Inc. (HUM) S - The National Law Review
Humana (HUM) is Rebounding to a Multi-Year Improvement in Margins and Returns - Insider Monkey
What Humana (HUM)'s Expanded Barostim Coverage Means For Shareholders - simplywall.st
Humana Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Humana Just Got a Massive Upgrade From Deutsche Bank: Price Target Nearly Doubles to $441 - AOL.com
Cigna downgraded, Humana upgraded: Wall Street’s top analyst calls - TipRanks
Cigna downgraded, Humana upgraded: Wall Street's top analyst calls - Yahoo Finance
Deutsche Bank upgrades Humana stock rating on earnings outlook - Investing.com
CVS Health Stock Is Soaring. Could the Rally Just Be Getting Started? - The Motley Fool
Deutsche Bank Upgrades Humana to Buy From Hold, Adjusts PT to $441 From $235 - marketscreener.com
North Dakota State Investment Board Makes New $1.52 Million Investment in Humana Inc. $HUM - MarketBeat
Humana Inc. (HUM) Enters Material Definitive Agreement for Capital and Liquidity Enhancement - GuruFocus
Humana Establishes Pre-Capitalized Trusts for Contingent Funding - TipRanks
Humana completes $1.5 billion pre-capitalized trust securities offering - StreetInsider
Humana (HUM) creates Horseshoe trust structure for long-dated senior note funding - Stock Titan
Here's Why Investors Should Stay Neutral on Humana Stock for Now - Yahoo Finance
HUM Stock Quote Price and Forecast - CNN
Humana Inc stock (US4456581077): lawsuit over Medicare claims data adds pressure around managed-care - AD HOC NEWS
Humana Just Ripped 48% in a Month. Is It Outperforming Other Healthcare Stocks Like UnitedHealth and Cigna? - 24/7 Wall St.
Humana Securities Lawsuit Against Humana Partially Survives Motion to Dismiss - TipRanks
Humana: Perhaps The 'Buy The Dip' Thesis Was Right All Along (Rating Upgrade) (NYSE:HUM) - Seeking Alpha
CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy - Yahoo Finance
Humana Inc. (HUM) Stock Analysis: Navigating Healthcare with a Solid Revenue Growth of 23.5% - DirectorsTalk Interviews
Zacks Research Has Optimistic View of Humana FY2026 Earnings - MarketBeat
Humana Expands Barostim Coverage What It Could Mean For Valuation - Yahoo Finance
Leuthold Group LLC Acquires New Holdings in Humana Inc. $HUM - MarketBeat
Humana Inc stock (US4456581077): Medicare Advantage focus after latest earnings update - AD HOC NEWS
Northwestern Mutual Wealth Management Co. Buys 321,277 Shares of Humana Inc. $HUM - MarketBeat
CVRx Gains Momentum With Revenue Growth, BENEFIT-HF Progress and Humana Coverage Win - TipRanks
Leeward Investments LLC MA Has $8.41 Million Position in Humana Inc. $HUM - MarketBeat
Humana (HUM) Valuation Check After Barostim Coverage Decision And Earnings Beat - simplywall.st
Glenview Capital Management Increases Stake in Humana (HUM) - GuruFocus
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc.HUM - Business Wire
Glenview adds Humana, exits Expedia, reduces Teva among Q1 trades - MSN
Glenview adds Humana, exits Expedia, reduces Teva among Q1 trades (HUM:NYSE) - Seeking Alpha
Humana (NYSE:HUM) Gains Attention Amid Healthcare Momentum In S&P 500 Index - Kalkine Media
Humana stock outlook: Is Wall Street bullish or bearish? - MSN
What is Zacks Research's Forecast for Humana Q2 Earnings? - MarketBeat
Humana (NYSE:HUM) Upgraded by Zacks Research to Hold Rating - MarketBeat
Morgan Stanley Adjusts Price Target on Humana to $217 From $146, Maintains Underweight Rating - marketscreener.com
Humana Stock Outlook: Is Wall Street Bullish or Bearish? - Yahoo Finance
Humana Inc. Stock 12‑Month Price Target Raised to $246.46, Implies 18% Downside - TradingView
Humana (HUM) Stock Price, News & Analysis $HUM - MarketBeat
Humana (HUM) price target increased by 15.35% to 254.49 - MSN
Humana Inc. stock underperforms Thursday when compared to competitors - MarketWatch
CVRx earns Humana Medicare Advantage win for Barostim - MassDevice
4 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
휴매너 (HUM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.37%
0.12%
자본화:
|
볼륨(24시간):